Literature DB >> 1313023

Protein-DNA interactions at a dioxin-responsive enhancer. Mutational analysis of the DNA-binding site for the liganded Ah receptor.

E S Shen1, J P Whitlock.   

Abstract

The liganded Ah receptor activates transcription by binding to a specific DNA-recognition motif within a dioxin-responsive enhancer upstream of the CYP1A1 gene. Analyses of mutant enhancers by gel retardation reveal that each base pair within the domain 5'CGTG(GCAC)3' is essential to the receptor-enhancer interaction. The three base pairs immediately flanking each end of the essential domain contribute less strongly to receptor binding. Analyses of enhancer function by transfection reveal that a mutation in the essential domain, which abolishes receptor-DNA binding, obliterates enhancer function. Mutations outside the essential domain, which diminish, but do not abolish, receptor-DNA binding, also obliterate enhancer function. Additionally, one mutation adjacent to the essential binding motif does not affect receptor-DNA binding, but destroys enhancer activity. These findings imply that transcriptional enhancement by the dioxin-responsive system cannot be predicted solely by the strength of the receptor-enhancer interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313023

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences.

Authors:  Y V Sun; D R Boverhof; L D Burgoon; M R Fielden; T R Zacharewski
Journal:  Nucleic Acids Res       Date:  2004-08-24       Impact factor: 16.971

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation.

Authors:  Carrie Hayes Sutter; Sridevi Bodreddigari; Christina Campion; Ryan S Wible; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2011-08-11       Impact factor: 4.849

3.  Lack of ligand-selective binding of the aryl hydrocarbon receptor to putative DNA binding sites regulating expression of Bax and paraoxonase 1 genes.

Authors:  Danica E DeGroot; Ai Hayashi; Michael S Denison
Journal:  Arch Biochem Biophys       Date:  2013-11-04       Impact factor: 4.013

Review 4.  Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.

Authors:  Troy D Hubbard; Iain A Murray; Gary H Perdew
Journal:  Drug Metab Dispos       Date:  2015-06-03       Impact factor: 3.922

Review 5.  The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells.

Authors:  Eszter Baricza; Viola Tamási; Nikolett Marton; Edit I Buzás; György Nagy
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

Review 6.  Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells.

Authors:  Nikki B Marshall; Nancy I Kerkvliet
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

7.  RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.

Authors:  Christoph F A Vogel; Eric Sciullo; Wen Li; Pat Wong; Gwendal Lazennec; Fumio Matsumura
Journal:  Mol Endocrinol       Date:  2007-09-06

8.  Aryl hydrocarbon-induced interactions at multiple DNA elements of diverse sequence--a multicomponent mechanism for activation of cytochrome P4501A1 (CYP1A1) gene transcription.

Authors:  R W Robertson; L Zhang; D S Pasco; J B Fagan
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

9.  Altered DNA binding specificity of Arnt by selection of partner bHLH-PAS proteins.

Authors:  Koshi Kinoshita; Yasuo Kikuchi; Yukie Sasakura; Masashi Suzuki; Yoshiaki Fujii-Kuriyama; Kazuhiro Sogawa
Journal:  Nucleic Acids Res       Date:  2004-06-09       Impact factor: 16.971

Review 10.  The search for endogenous activators of the aryl hydrocarbon receptor.

Authors:  Linh P Nguyen; Christopher A Bradfield
Journal:  Chem Res Toxicol       Date:  2007-12-13       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.